KRT19 and cancer: Moreover, KMplot confirmed different clinical outcomes regarding KRT19 expression in various cancers, including a good prognosis with gastric cancer (n = 876, hazard ratio (HR) = 0.83, 95% confidence interval (CI) = 0.7–0.98, p = 0.026), whereas lung (n = 1926, hazard ratio (HR) = 1.31, 95% confidence interval (CI) = 1.15–1.48, p = 3.6e-05) and ovarian (n = 1306, hazard ratio (HR) = 1.09, 95% confidence interval (CI) = 0.96–1.24, p = 0.19) cancers were associated with poor outcomes (Figure S3).